Events

Dubai – September 08, 2026 -- DAMAC Properties has handed over more than 50,000 homes to date and awarded over USD 2.72 billion in construction contracts during the first half of 2026, as the UAE's largest private developer targets 8,800-plus residential unit deliveries this year.

DAMAC targets 8,800 units across five key communities in 2026

The handover programme spans DAMAC Lagoons, DAMAC Hills, DAMAC Hills 2, Chic Tower and Elegance Tower. The developer currently holds more than 55,000 units and over 100 million sq. ft. of project area in planning and development, laying groundwork for deliveries extending into 2027.

Shanghai – September 08, 2026 -- Mabwell (688062.SH, 02493.HK) reported that its anti-ST2 monoclonal antibody 9MW1911 reduced the annualized rate of severe COPD exacerbations by 100% in the 900 mg dose group compared with placebo, according to Phase Ib/IIa data presented as a poster at the European Respiratory Society International Congress 2026 (ERS 2026).

Trial enrolled 80 COPD patients across four dose arms

The randomized, double-blind, placebo-controlled study (9MW1911-C03) enrolled 80 former smokers with moderate-to-severe COPD, randomizing participants to intravenous 9MW1911 at 100 mg, 300 mg, 600 mg, or 900 mg, or placebo, every four weeks. Most participants had blood eosinophil counts of 300 cells/μL or below.

Westport, Conn. – September 08, 2026 -- Pink Aid, the sole national nonprofit providing emergency financial aid to breast cancer patients, has launched the 'Visionary Circle,' a corporate advisory group aimed at expanding its national reach and fundraising capacity.

Breast cancer treatment drains $3.14 billion annually from U.S. patients

Out-of-pocket costs for breast cancer care can exceed $100,000 per year for some families, according to Pink Aid. Roughly one in three patients faces severe financial hardship during treatment, a figure that climbs to 78% among patients in low- and middle-income communities.

Pink Aid has distributed $6 million to 9,200 patients since 2015

The organization partners with more than 1,200 hospital social workers across 400 hospitals nationwide, delivering emergency funds within 48 hours to cover rent, utilities, groceries, and transportation costs during active treatment.

Berlin – September 08, 2026 -- BLUETTI unveiled the Pioneer 5000 E-Generator at IFA Berlin 2026, a professional-grade electric power unit designed to replace fuel generators on construction sites with a zero-emission alternative.

Pioneer 5000 delivers 5 kW continuous power with 18 kW peak surge capacity

The unit is built to run high-inrush equipment including electric drills, cut-off saws, air compressors and water pumps. Its 5.12 kWh LiFePO4 battery can be expanded up to 35 kWh, enabling extended off-grid operation for professional crews.

Generator carries IP65 and IK10 ratings for jobsite durability

The Pioneer 5000 is engineered for rain, dust and uneven terrain, featuring an impact-resistant frame, off-road wheels, and functional performance across a temperature range of -20°C to 55°C.

San Francisco – September 08, 2026 -- Docusign (Nasdaq: DOCU) will make its Model Context Protocol (MCP) Server generally available to every AI agent worldwide on September 30, letting agreement intelligence and governed contract actions be called natively from Claude, ChatGPT, Gemini, Copilot, Slack and any MCP client.

Docusign extends two decades of API-first infrastructure to AI agents

The company's eSignature technology is already embedded in more than 1,100 partner-built applications. The new MCP Server extends that same open architecture to agents using Docusign's Iris AI engine across Intelligent Agreement Management and advanced Contract Lifecycle Management (CLM) workflows, giving agents access to past negotiations, accepted terms, clauses and company policy.

Irvine, Calif. – September 08, 2026 -- Crossware, an enterprise email signature management provider, has expanded its agreement with Ingram Micro to distribute its Microsoft 365 signature platform through Ingram Micro's Xvantage marketplace using Microsoft Marketplace Private Offers, broadening access for Cloud Solutions Providers across North America.

Crossware now processes more than five million emails daily across its global customer base

The company's platform, used by organizations from start-ups to government agencies, has scaled rapidly across the European Union and Asia-Pacific over the past five years. The North American rollout marks a planned expansion of that footprint, building on a channel relationship with Ingram Micro established in 2019.

Hangzhou – September 08, 2026 -- SCANOLOGY has introduced two new optical 3D scanning systems, TrackScan Sharp-Z and TrackScan GO, targeting manufacturers that need to move measurement equipment between large components and confined production spaces.

TrackScan Sharp-Z extends tracking range to 12 meters for oversized parts

The system uses Fully Self Tracking technology that automatically rotates the tracker to follow the 3D scanner, cutting down on repositioning during inspection of large components such as aircraft structures, commercial vehicles, and energy equipment.

New York – September 08, 2026 -- XTEND, an AI-powered defense robotics and software company, will begin trading on the New York Stock Exchange under the ticker symbol XTND following a business combination with JFB Construction Holdings.

XTEND merges with JFB Construction Holdings to form XTEND AI Robotics

The combined entity will operate under the new name XTEND AI Robotics once the transaction closes. XTEND CEO Aviv Shapira said the listing marks the next chapter in the company's growth.

AT&T marks 125 years as an NYSE-listed company

AT&T (NYSE: T) is observing the 125th anniversary of its NYSE listing, having first traded on the exchange on this date in 1901. The telecommunications carrier ranks as the 11th-longest continuously listed company on the NYSE. Brett Feldman, AT&T's Senior Vice President, Treasurer and Head of Investor Relations, is scheduled to discuss the milestone on NYSE's Taking Stock program later today.

Stuttgart – September 08, 2026 -- Pharma Deutschland's Baden-Württemberg chapter and MEDIVERBUND AG kicked off development of a regional action plan aimed at strengthening self-medication as a lever to relieve pressure on doctors' offices and build a more resilient healthcare system.

Industry and physician groups agree self-medication can free up doctor capacity

At the "Selbstverständlich Selbstmedikation" event, representatives from politics, medicine, pharmacies, health insurers and the pharmaceutical industry discussed conditions needed to expand patient self-treatment for minor ailments. Dr. Traugott Ullrich, chairman of Pharma Deutschland's Baden-Württemberg association, argued that low-threshold self-medication allows patients to treat or prevent minor health issues while pharmacies handle counseling and physicians retain capacity for more complex cases.

Everett, Mass. – September 08, 2026 -- More than 1,300 workers at Encore Boston Harbor have walked off the job after management refused to bargain in good faith, disrupting operations at a resort that generated $847 million in revenue last year.

Teamsters authorized the strike with a 97 percent vote

On August 20, members of Teamsters Local 25 voted 97 percent in favor of authorizing a strike if a fair contract was not reached. The action jointly involves Teamsters Local 25 and UNITE HERE Local 26, covering roles across warehouse, horticulture, call center, cage cashier, limo driver, dispatcher, traffic attendant, valet, and guest experience positions.

Burlington, Mass. – September 08, 2026 -- Azenta, Inc. (Nasdaq: AZTA) has received full repayment, ahead of maturity, of a $35 million secured vendor loan tied to its divestiture of B Medical Systems S.à r.l., closing out the transaction with the entire $63 million purchase price now collected in cash.

Azenta collects $35 million vendor loan before maturity

Azenta Germany GmbH, a wholly owned subsidiary, had extended the secured term loan to buyer Thelema S.à r.l. as part of the sale that closed July 1, 2026. The loan was secured by a pledge over B Medical Systems' equity interests. Thelema repaid the principal along with all accrued interest, and Azenta released the share pledge that secured the debt.

Total cash proceeds reach $63 million

With the vendor loan settled, Azenta has now received the full $63 million purchase price for B Medical Systems in cash, eliminating the credit exposure the company carried since the deal closed.

Carlsbad – September 08, 2026 -- Tyra Biosciences, Inc. (Nasdaq: TYRA) will disclose initial clinical results from its SURF302 Phase 2 study of oral dabogratinib in intermediate risk non-muscle invasive bladder cancer (IR NMIBC) during a conference call scheduled for September 9, 2026, at 8:00 am ET.

Tyra sets September 9 call to unveil first SURF302 data

The clinical-stage biotech confirmed the call and webcast will present initial efficacy and safety data from the ongoing SURF302 trial, marking the first public disclosure of results for dabogratinib in this bladder cancer indication.

Dabogratinib targets FGFR3-driven tumors as lead pipeline asset

Dabogratinib is Tyra's lead precision medicine candidate, developed as a potential first-in-class selective FGFR3 inhibitor. Beyond IR NMIBC, the company is advancing the drug for low-grade upper tract urothelial cancer (LG-UTUC) and achondroplasia (ACH).

Toronto – September 08, 2026 -- The Fertility Partners (TFP), Canada's largest fertility clinic network, has completed the sale of Illume Fertility, a Connecticut- and New York-based fertility practice, to IVI RMA North America, closing the deal on September 3, 2026.

TFP divests U.S. asset to concentrate capital on Canadian expansion

The transaction removes Illume from TFP's portfolio and redirects the company's capital, resources, and leadership attention toward growth opportunities across Canada. TFP CEO Heather Stark said the move reflects a deliberate portfolio decision, stating the company's strongest opportunities are in Canada and that the sale allows TFP to focus fully on building the country's leading fertility network.

Richmond, Va. – September 08, 2026 -- Markel, the insurance operations within Markel Group Inc. (NYSE: MKL), has entered a strategic collaboration with Midwest General Insurance Agency, LLC, an Acrisure subsidiary, to expand workers compensation insurance offerings in California.

Markel Targets California Small Business Workers Comp Growth

Midwest, a full-service managing general agency (MGA) with more than 20 years of experience in California workers compensation, specializes in the small workers compensation sector and provides online quoting for agency partners. The agency has built turnkey capabilities spanning marketing, underwriting, policy issuance, claims, and loss control.

Winnipeg, MB – September 08, 2026 -- Juvonno has expanded its free Open API ecosystem to more than 23 software developers, giving clinics across Canada, the UK, and the USA access to AI-powered reception, reporting, and charting tools without added licensing costs.

Juvonno's free Open API now supports 23-plus third-party developers

The clinic management software provider is building connected solutions ranging from AI-driven reception systems to automated reporting and charting tools, all integrated with its core practice management platform. The API remains free for all Juvonno customers, removing a common cost barrier to third-party integration in the allied health software sector.

Stamford – – September 08, 2026 -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) has opened its 77th dispensary in Florida, pushing its nationwide retail count to 178 locations.

Curaleaf Riverview Opens in Tampa Bay's Fast-Growing South Shore Corridor

The new dispensary, located at 10422 US Hwy 301 S in Riverview, FL, serves a suburban market the company describes as transitioning from rural land along the Alafia River into a hub for young professionals and businesses. The location sits near Tampa, Brandon and Apollo Beach, an area Curaleaf cites for ongoing residential and retail growth.

Store Stocks Florida-Exclusive Reef Flower Alongside Multiple Proprietary Brands

Curaleaf Riverview carries the company's Florida-exclusive Reef flower, Dark Heart ultra-premium flower, FIND flower, Anthem pre-rolls and the Select Briq 2 all-in-one vape, targeting medical cannabis patients in the state.

Macau – September 08, 2026 -- Global eye care nonprofit Orbis International has launched its first-ever simulation-based training project in Macau, marking 20 years of local partnership that has raised more than US$33 million for the organization's work in China and worldwide.

Orbis brings 70 clinicians from eight Chinese hospitals for Flying Eye Hospital training

The project engages 70 ophthalmologists and nurses from eight Orbis partner hospitals across China, who will receive advanced training and mentorship aboard the Flying Eye Hospital aircraft and at Kiang Wu Nursing College of Macau. Training covers simulated cataract, glaucoma, strabismus, medical retina, and nursing specialties. Orbis states these professionals collectively serve more than 245,000 patients annually in China.

Melbourne – September 08, 2026 -- Dimerix Limited (ASX: DXB) has secured non-dilutive loan facility agreements worth up to A$34 million with a syndicate of Australian and U.S. lenders, expanding on its previously announced A$10 million SKIPTAN facility.

Dimerix locks in A$34 million loan facility from Australian, U.S. lenders

The new terms are substantially consistent with the earlier SKIPTAN agreement, with minor amendments made to standardise conditions across all lenders. The structure gives Dimerix the option to expand total commitments to A$50 million on or before March 31, 2027, though the company currently has no plans to draw on that additional capacity.

Alameda, Calif. – September 08, 2026 -- Acepodia (6976: TT) said the U.S. Food and Drug Administration has cleared its Investigational New Drug application for ACE723, a GPC3-targeted dual-payload antibody-drug conjugate, clearing the way for a Phase 1 clinical trial in unresectable or metastatic hepatocellular carcinoma (HCC).

FDA clearance advances first candidate from Acepodia's AD2C platform into human trials

ACE723 is built on Acepodia's proprietary Antibody-Dual-Drugs Conjugation (AD2C) platform, which combines antibody engineering, medicinal chemistry and tumor biology to deliver two cytotoxic payloads to a single tumor-targeting antibody. The compound targets GPC3, a tumor-associated antigen frequently expressed in HCC tumor cells.

Bridgewater, N.J. – September 08, 2026 -- Insmed Incorporated (Nasdaq: INSM) has issued inducement equity awards to 128 newly hired employees, a move tied to its ongoing workforce expansion in the biopharmaceutical sector.

Insmed grants 115,320 restricted stock units to new hires as employment inducement

The awards, approved by Insmed's Compensation Committee, were granted on August 31, 2026, under the company's 2025 Inducement Plan. The plan is structured to comply with Nasdaq Listing Rule 5635(c)(4), which permits equity grants as a material inducement for new employees without requiring shareholder approval.